The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Feb. 19, 2013
Applicant:

Mystic Pharmaceuticals, Inc., Cedar Park, TX (US);

Inventors:

Timothy R. Sullivan, Austin, TX (US);

Jeffrey Nelson, Round Rock, TX (US);

Assignee:

Mystic Pharmaceuticals, Inc., Cedar Park, TX (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/30 (2006.01); A61M 11/06 (2006.01); A61M 15/08 (2006.01); B05B 11/02 (2006.01); A61M 11/00 (2006.01); A61M 15/00 (2006.01); A61M 5/24 (2006.01); A61M 15/06 (2006.01); B05B 11/00 (2006.01); B05B 11/04 (2006.01); B05B 11/06 (2006.01);
U.S. Cl.
CPC ...
A61M 5/30 (2013.01); A61M 11/002 (2014.02); A61M 11/007 (2014.02); A61M 11/06 (2013.01); A61M 15/0003 (2014.02); A61M 15/004 (2014.02); A61M 15/0028 (2013.01); A61M 15/0031 (2014.02); A61M 15/0036 (2014.02); A61M 15/0051 (2014.02); A61M 15/08 (2013.01); B05B 11/0081 (2013.01); B05B 11/02 (2013.01); A61M 5/2425 (2013.01); A61M 15/06 (2013.01); A61M 2202/0468 (2013.01); A61M 2202/064 (2013.01); A61M 2205/073 (2013.01); A61M 2205/273 (2013.01); A61M 2205/276 (2013.01); A61M 2205/583 (2013.01); A61M 2205/584 (2013.01); A61M 2205/6081 (2013.01); A61M 2206/16 (2013.01); B05B 11/0035 (2013.01); B05B 11/0083 (2013.01); B05B 11/048 (2013.01); B05B 11/062 (2013.01); B05B 11/3056 (2013.01); B05B 11/3057 (2013.01);
Abstract

Intranasal delivery devices include dosage forms containing medical compositions for use in the intranasal devices, and methods of delivering medical compositions to the nasal mucosa of users. The devices dispense a predetermined quantity of fluid into the nasal passage of a user, in which the predetermined quantity of fluid is contained in, or produced in a dosage form or blister that is crushed by a plunger with sufficient force to drive the dosage form against a piercing mechanism, piercing the dosage form and forcing the liquid contents from the dosage form and through a delivery channel into a spray to be directed into the nasal passage of a user. The plunger is connected to a trigger device by a linkage that confers a mechanical advantage to the trigger mechanism.


Find Patent Forward Citations

Loading…